Tuesday, January 4, 2011

TRDX to Seek Growth Through Launch of Pharmaceutical Distribution Division; Currently Approved in New York & Florida, Other States Pending

JERICHO, NY--(Marketwire - 01/04/11) - SciMeDent Health, Corp. f/k/a Trend Exploration, Inc. ("TRDX" or the "Company") (Pinksheets:TRDX - News) today announces that Preferred Distribution, Inc., its medical and dental supplies distribution subsidiary ("Preferred") (www.preferreddist.com), is in the process of launching a pharmaceutical distribution division.

The implementation which initially consists of Preferred registering as an out of state wholesaler of pharmaceuticals is well underway. Preferred has successfully registered in New York, Florida and Washington. Additional registrations are pending in New Jersey and California.

Dr. Jan Stahl, CEO of TRDX, commented: "Preferred has been working for quite some time to prepare for this new division. This new division provides the Company with a tremendous opportunity for significant revenue growth. We look forward to its implementation and the value it could possibly bring to the Company and its shareholders."

About SCIMEDENT f/k/a Trend Exploration, Inc. (Pinksheets:TRDX - News)

SciMeDent (www.scimedenthealth.com) is a company focused on being a leading developer and marketer of products and services for medicine, dentistry and life sciences. SciMeDent plans to achieve growth initially through mergers and acquisitions.

Cautionary Statement Regarding Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological or industry changes and uncertainties related to the development of the Company's business model. The actual results the Company may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

No comments:

Disclaimer

Average Joe's Picks is an independent electronic medium, which provides industry data and information on publicly traded companies for the use of our readers. Furthermore, the provided data should not be used as the sole basis for making any investment decision. The individual investor's own due diligence is of the utmost importance and highly recommended.